Stocks
argenx SEARGX
NASDAQHealthcareBiotechnology$700.45-1.19%
A biotechnology company focused on developing antibody-based therapies for autoimmune diseases and cancer. Its lead product, efgartigimod (marketed as Vyvgart), targets rare autoimmune conditions and has become a key revenue driver as the company expands into additional indications. Investors track ...
Market Cap: $43.3B52W Range: $510.06 – $934.62
Congressional Interest in argenx SE (ARGX)
2 members of Congress have disclosed 2 trades in argenx SE (ARGX), a Healthcare company. The buy/sell breakdown shows 0 purchases versus 2 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
2
Unique Politicians
2
Buys
0
Sells
2
Who in Congress Is Trading ARGX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-07-10 | Daniel Goldman | sell | $1K – $15K |
| 2021-12-17 | MICHAEL T. MCCAUL | sell | $1M+ |